Canadian cattle producers have a new pain control option for their animals thanks to a Calgary-based company.
Solvet has formally launched Meloxicam Oral Suspension, a liquid formulation that is administered orally to treat pain resulting from injuries, illness, calving and surgical procedures, including castration.
The release coincides with the implementation of new pain management requirements on January 1, 2016. Under Canada’s new beef code of practice, producers will be required to use pain mitigation during dehorning of calves after horn bud attachment (typically 2-3 months of age) and when castrating calves over nine months.
As a result, the industry has been looking for a pain control option that’s easy to administer and affordable.
“We are driven by the requests of our clients and there has been an increase in demand regarding the care and handling of cattle,” noted Dr. Merle Olson, vice-president of research and development for Solvet, in a news release issued Tuesday. “As of the new year, the Code of Practice for the Care and Handling of Beef Cattle will require producers to use pain control in consultation with a veterinarian to mitigate pain. Meloxicam Oral Suspension is the first medication in Canada with a label claim for reducing pain associated with castration, and is offered at a competitive price.”
The company says the solution is rapidly absorbed and offers therapeutic pain relief lasting up to 56 hours in cattle.
Developed by Alberta Veterinary Laboratories, the Alberta Livestock and Meat Agency (ALMA), Agriculture and Agri-Food Canada and Veterinary Agri-Health Services were also involved in researching oral meloxicam for castration pain mitigation.
A formal launch of Meloxicam Oral Suspension was held during the CanWest Veterinary Conference in Banff in October.
Solvet suggests contacting your local veterinarian for more information.
- What’s Next for the Beef Code of Practice?
- Beef Research School: What you Need to Know About the New Beef Code of Conduct